NCT04800822 2026-06-04PF-07284892 in Participants With Advanced Solid TumorsPfizerPhase 1 Terminated53 enrolled
NCT04645160 2026-06-03Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Recruiting31 enrolled